BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27822067)

  • 1. BCL3 exerts an oncogenic function by regulating STAT3 in human cervical cancer.
    Zhao H; Wang W; Zhao Q; Hu G; Deng K; Liu Y
    Onco Targets Ther; 2016; 9():6619-6629. PubMed ID: 27822067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell CLL/lymphoma 3 promotes glioma cell proliferation and inhibits apoptosis through the oncogenic STAT3 pathway.
    Wu J; Li L; Jiang G; Zhan H; Wang N
    Int J Oncol; 2016 Dec; 49(6):2471-2479. PubMed ID: 27748795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
    Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
    Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of long non-coding RNA LINC00518 inhibits cervical cancer proliferation and metastasis by modulating JAK/STAT3 signaling.
    Wang DW; You D; Dong J; Liu TF
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):496-506. PubMed ID: 30720156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl3 selectively promotes metastasis of ERBB2-driven mammary tumors.
    Wakefield A; Soukupova J; Montagne A; Ranger J; French R; Muller WJ; Clarkson RW
    Cancer Res; 2013 Jan; 73(2):745-55. PubMed ID: 23149915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derlin1 functions as an oncogene in cervical cancer via AKT/mTOR signaling pathway.
    Li L; Liu M; Zhang Z; Zhang W; Liu N; Sheng X; Wei P
    Biol Res; 2019 Feb; 52(1):8. PubMed ID: 30808417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene regulation by BCL3 in a cervical cancer cell line.
    Maldonado V; Espinosa M; Pruefer F; Patiño N; Ceballos-Canciono G; Urzua U; Juretic N; Melendez-Zajgla J
    Folia Biol (Praha); 2010; 56(4):183-93. PubMed ID: 20974051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcription.
    Brocke-Heidrich K; Ge B; Cvijic H; Pfeifer G; Löffler D; Henze C; McKeithan TW; Horn F
    Oncogene; 2006 Nov; 25(55):7297-304. PubMed ID: 16732314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
    Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
    Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer.
    Scholz A; Heinze S; Detjen KM; Peters M; Welzel M; Hauff P; Schirner M; Wiedenmann B; Rosewicz S
    Gastroenterology; 2003 Sep; 125(3):891-905. PubMed ID: 12949733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl3 Bridges LIF-STAT3 to Oct4 Signaling in the Maintenance of Naïve Pluripotency.
    Chen CY; Lee DS; Yan YT; Shen CN; Hwang SM; Lee ST; Hsieh PC
    Stem Cells; 2015 Dec; 33(12):3468-80. PubMed ID: 26303070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stat3 activation in human endometrial and cervical cancers.
    Chen CL; Hsieh FC; Lieblein JC; Brown J; Chan C; Wallace JA; Cheng G; Hall BM; Lin J
    Br J Cancer; 2007 Feb; 96(4):591-9. PubMed ID: 17311011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
    Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
    J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
    Jin X; Jiao X; Jiao J; Zhang T; Cui B
    Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
    Zhang P; Yang B; Yao YY; Zhong LX; Chen XY; Kong QY; Wu ML; Li C; Li H; Liu J
    Gynecol Oncol; 2015 Dec; 139(3):529-35. PubMed ID: 26432044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression of microtubule-associated protein 7 functioned as a contributor to cervical cancer cell migration and is predictive of adverse prognosis.
    Tang N; Lyu D; Chang JF; Liu ZT; Zhang Y; Liu HP
    Cancer Cell Int; 2020; 20():354. PubMed ID: 32760221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA SNHG12 promotes the progression of cervical cancer via modulating miR-125b/STAT3 axis.
    Jin XJ; Chen XJ; Zhang ZF; Hu WS; Ou RY; Li S; Xue JS; Chen LL; Hu Y; Zhu H
    J Cell Physiol; 2019 May; 234(5):6624-6632. PubMed ID: 30246459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia accelerates vascular repair of endothelial colony-forming cells on ischemic injury via STAT3-BCL3 axis.
    Lee SH; Lee JH; Han YS; Ryu JM; Yoon YM; Han HJ
    Stem Cell Res Ther; 2015 Jul; 6(1):139. PubMed ID: 26219963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical, biologic and mechanistic analysis of the role of ZNF692 in cervical cancer.
    Zhu B; Pan Y; Zheng X; Zhang Q; Wu Y; Luo J; Li Q; Lu E; Xu L; Jin G; Ren B
    Gynecol Oncol; 2019 Feb; 152(2):396-407. PubMed ID: 30466806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferating cell nuclear antigen promotes cell proliferation and tumorigenesis by up-regulating STAT3 in non-small cell lung cancer.
    Wang L; Kong W; Liu B; Zhang X
    Biomed Pharmacother; 2018 Aug; 104():595-602. PubMed ID: 29803172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.